What question did this study set out to answer?

This study investigates how social determinants of health affect treatment access and survival outcomes in metastatic non-small cell lung cancer.

Impact of social determinants of health on treatment patterns and outcomes in metastatic non-small cell lung cancer

View Full Paper

Ask AI

Bookmark

This study investigates how social determinants of health affect treatment access and survival outcomes in metastatic non-small cell lung cancer.
Retrospective analysis of 869 patients with metastatic non-small cell lung cancer using U.S. claims and electronic medical records.
Descriptive analysis of patient characteristics, treatment patterns, and social determinants.
Kaplan-Meier methods estimated overall survival while multivariable logistic regression assessed the impact of social determinants on treatment receipt.
77% of patients received systemic first-line treatment, with Black patients showing lower likelihood of receiving immunotherapy (OR 0.47; P = 0.0346).
Median time to treatment was longer for Black patients (49 days) compared to White patients (40 days).
Median overall survival was shorter for Black patients (11.2 months) compared to White patients (13.6 months), although not statistically significant.

No takes yet. Share an insight, caveat, or question.

Retrospective study reveals treatment disparities and outcomes in metastatic lung cancer patients, indicating a need for equitable care.

Hill et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark